New Trends and Tactics in Outsourcing
As industry clinical trial partners seek greater patient diversity and operational efficiencies in drug development, our October issue of Applied Clinical Trials explores some of the related outsourcing methods that are emerging.
Within the push for greater diversity of patient populations in clinical research has come more attention on inclusive trial designs. Key to this effort have been new methods of outsourcing that have emerged in recent years. This has occurred in step with the rise of integrated research organizations (IROs), which are bringing trials directly to community-based research centers and doctors’ offices, as opposed to more traditional academic sites. No matter how you slice it, barriers to clinical trial participation are being broken down to allow greater access for patients. Our
We have four features on tap this month, with the
In addition to our regular coverage, we’re happy to share some highlights from DPHARM 2024. Representing ACT was Nico Saraceno, editor of our sister publication, Pharmaceutical Commerce, who attended sessions and spoke with industry leaders on-site in Philadelphia. For full coverage, visit
Mike Hennessy Jr is president and CEO of MJH Life Sciences®
Articles in this issue
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025